Erratum: An oncogenic enhancer encodes selective selenium dependency in AML (Cell Stem Cell (2022) 29(3) (386–399.e7), (S1934590922000030), (10.1016/j.stem.2022.01.003))

Kenneth Eagle, Yajian Jiang, Xiangguo Shi, Minhua Li, Nikolaus D. Obholzer, Tianyuan Hu, Monika W. Perez, Jošt Vrabič Koren, Ayumi Kitano, Joanna S. Yi, Charles Y. Lin, Daisuke Nakada

Research output: Contribution to journalComment/debatepeer-review

5 Scopus citations

Abstract

(Cell Stem Cell 29, 386–399.e1–e7; March 3, 2022) In the originally published version of this manuscript, the author Nikolaus D. Obholzer was incorrectly listed as Nikolaus P. Obholzer. Additionally, N.D.O.’s declaration of interests information was inadvertently omitted. To address this, the authors have now corrected the author's name and included N.D.O.’s declaration of interests (“N.D.O. is a shareholder of Kronos Bio”). The authors apologize for the oversight and for any resulting confusion.

Original languageEnglish (US)
Pages (from-to)650
Number of pages1
JournalCell Stem Cell
Volume29
Issue number4
DOIs
StatePublished - Apr 7 2022

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Cell Biology

Fingerprint

Dive into the research topics of 'Erratum: An oncogenic enhancer encodes selective selenium dependency in AML (Cell Stem Cell (2022) 29(3) (386–399.e7), (S1934590922000030), (10.1016/j.stem.2022.01.003))'. Together they form a unique fingerprint.

Cite this